Acuerdo Marco para el suministro de medicamentos sin competencia para los hospitales del Servicio Cántabro de Salud (Principios activos Luspatercept, Mavacamten, Fedratinib, Belata...
Acuerdo Marco para el suministro de medicamentos sin competencia para los hospitales del Servicio Cántabro de Salud (Principios activos Luspatercept, Mavacamten, Fedratinib, Belatacept, Abatacept, Deucravacitinib, Ipilimumab, Ozanimod).
Buyer
Servicio Cántabro de Salud
Value
€73,624,963
Published
24 Sept 2026
Closes
Not provided
Procurement details
Source
TED (EU)
Country
Spain (ES)
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot LOT-0001 Lote 1. Reblozyl (Luspatercept)
€965,602
Lote 1. Reblozyl (Luspatercept)
Delivery: ES130 · Spain
Lot LOT-0002 Lote 2. Camzyos (Mavacamten)
€2,537,198
Lote 2. Camzyos (Mavacamten)
Delivery: ES130 · Spain
Lot LOT-0003 Lote 3. Inrebic (Fedratinib)
€200,086
Lote 3. Inrebic (Fedratinib)
Delivery: ES130 · Spain
Lot LOT-0004 Lote 4. Nulojix (Belatacept)
€775,680
Lote 4. Nulojix (Belatacept)
Delivery: ES130 · Spain
Lot LOT-0005 Lote 5. Orencia (Abatacept)
€9,252,563
Lote 5. Orencia (Abatacept)
Delivery: ES130 · Spain
Lot LOT-0006 Lote 6. Sotyktu (Deucravacitinib)
€95,745
Lote 6. Sotyktu (Deucravacitinib)
Delivery: ES130 · Spain
Lot LOT-0007 Lote 7. Yervoy (Ipilimumab)
€7,577,037
Lote 7. Yervoy (Ipilimumab)
Delivery: ES130 · Spain
Lot LOT-0008 Lote 8. Zeposia (Ozanimod hidrocloruro)
€683,579
Lote 8. Zeposia (Ozanimod hidrocloruro)
Delivery: ES130 · Spain
Documents
Unlock document linkTED notice 657724-2026
24 Sept 2026
Award notice · Web page
Contains information from TED (Tenders Electronic Daily), © European Union, reused under CC BY 4.0.